Skip to content

RAinfo.org

Regulatory Affairs Information

  • Home
  • About RAinfo
  • Regulatory Affairs Learning
  • Regulatory Authorities
  • Regulatory Journals
  • Regulatory News RSS Feeds
  • Regulatory Newsletters
  • Regulatory Posts
  • Regulatory Tools

Summary Basis of Decision for Asparlas​Health Canada RSS – Drug Products, Drugs and Health Products

Written by

 Health Canada Summary Basis of Decision 2024-06-11. Asparlas, calaspargase pegol, 3,750 units/5 mL, solution, Servier Canada Inc. Submission Control Number 268282

​

Share this:

  • Share on X (Opens in new window) X
  • Share on Facebook (Opens in new window) Facebook

Like this:

Like Loading...

Related

July 22, 2024 ·

Post navigation

« Final Guidance Focuses on Radiolabeled Mass Balance Studies of Investigational Drugs​Regulatory Affairs
Summary Basis of Decision for Jamteki​Health Canada RSS – Drug Products, Drugs and Health Products »
Powered by WordPress.com. Theme: Edda by Mel Choyce
Translate »

Discover more from RAinfo.org

Subscribe now to keep reading and get access to the full archive.

Continue reading

%d